期刊文献+

杂合膜包覆的纳米颗粒研究进展

Advances in Research on Hybrid Membrane-Coated Nanoparticles
原文传递
导出
摘要 随着纳米技术的不断发展,纳米颗粒被广泛应用于构建药物递送系统。在纳米颗粒表面修饰天然细胞膜,不仅能减轻纳米颗粒的生物毒性和免疫原性,也能使其获得长循环、免疫逃逸、同源靶向等复杂生物活性。同时含有2种及以上细胞膜成分的杂合膜则具备了来自于不同细胞的功能和生物学特性,可以实现多样化的递送目的。综述了杂合膜包覆的纳米颗粒研究进展,并对其在生物医学领域的应用前景进行了展望。 With the continuous development of nanotechnology,nanoparticles are widely used for the construction of drug delivery systems.Modifying the surface of nanoparticles with natural cell membrane can not only reduce the biological toxicity and immunogenicity of nanoparticles,but also endow them with complex biological activities,including long-term circulation,immune evasion and homologous targeting.The hybrid membrane,which simultaneously contains two or more cell membrane components,has the functions and biological characteristics derived from different cells,achieving diversified delivery purposes.This article reviews the research progress of hybrid membrane-coated nanoparticles and envisions their potential applications in biomedicine field.
作者 何磊 夏叶宁 李威 HE Lei;XIA Yening;LI Wei(School of Health Science and Engineering,University of Shanghai for Science and Technology,Shanghai 200093,China;Department of Nanomedicine,Naval Medical University/Shanghai Key Laboratory of Cell Engineering,Shanghai 200433,China)
出处 《药学进展》 CAS 2024年第3期207-220,共14页 Progress in Pharmaceutical Sciences
基金 上海市优秀学术带头人计划(No.22XD1404700) 上海市浦江人才计划(No.2021PJD080) 中国博士后科学基金(No.2021MD703948)。
关键词 杂合膜 杂合膜包覆的纳米颗粒 生物医学 纳米材料 hybrid membrane hybrid membrane-coated nanoparticle biomedicine nanomaterial
  • 相关文献

参考文献8

二级参考文献69

  • 1Quoc-Viet Le,Jaiwoo Lee,Hobin Lee,Gayong Shim,Yu-Kyoung Oh.Cell membrane-derived vesicles for delivery of therapeutic agents[J].Acta Pharmaceutica Sinica B,2021,11(8):2096-2113. 被引量:9
  • 2Palucka K, Banchereau J (2012) Cancer immunotherapy via dendritic cells. Nat Rev Cancer 12:265-277.
  • 3Schuler G, Steinman RM (1997) Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med 186:1183- 1187.
  • 4Melief CJM (2008) Cancer immunotherapy by dendritic cells. Immunity 29:372-383.
  • 5Mellman I, Coukos G, Dranoff G (2011) Cancer immunotherapy comes of age. Nature 480:480-489.
  • 6Kantoff PW, Higano CS, Shore ND et al (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411-422.
  • 7Ledford H (2015) Therapeutic cancer vaccine survives biotech bust. Nature 519:17-18.
  • 8Ledford H (2013) Immunotherapy's cancer remit widens. Nature 497:544.
  • 9Irvine DJ, Hanson MC, Rakhra K et al (2015) Synthetic nanoparticles for vaccines and immunotherapy. Chem Rev 115:11109-11146.
  • 10Cambi A, Lidke DS, Arndt-Jovin DJ et al (2007) Ligand-conju- gated quantum dots monitor antigen uptake and processing by dendritic cells. Nano Lett 7:970-977.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部